Intranasal Allergen Challenge in Pla2g5-Null Mice
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Brigham and Women's Hospital, Harvard University, University of California, San Diego
Variable analysis
- Exposure to Alternaria alternata extract (25 μg in 20 μL PBS) vs. PBS alone (20 μL)
- Single dose of Alternaria alternata extract (100 μg) with euthanasia at 1h or 3h
- Exposure to mouse rIL-33 (100 ng/dose) with or without LA (132 nM), OA (106 nM), or AA (99 nM)
- Not explicitly mentioned
- C57/BL6 wild-type (Wt) mice
- Pla2g5-null mice
- Age of mice (9-12 weeks old males)
- Route of administration (intranasal)
- Dosing schedule (days 0, 3, 6, and 9, with euthanasia 18h after last dose or 1h/3h after single dose)
- Positive control: C57/BL6 wild-type (Wt) mice
- Negative control: Pla2g5-null mice
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!